GBA1 and LRRK2 – From Genetic Risk to the Clinic
Grand Challenges in Parkinson’s Disease brings together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest Parkinson’s disease research. The 2021 symposium will focus on the influence of genetic risk factors on cell and brain biology, including risk for Parkinson’s and the roles of organellar trafficking, lipid metabolism, the endolysosomal system and neuropathology. Speakers also will discuss how genetic factors may be leveraged for treatment with a special focus on clinical trials, drug discovery and biomarker development that target GBA1 and LRRK2.
Van Andel Institute and The Cure Parkinson’s Trust are thrilled to once again host Rallying to the Challenge, a meeting designed for and by people with Parkinson’s, advocates and care partners that delves into how the Parkinson’s community can impact and accelerate research.
Please note, the 2021 symposium is tentatively planned as in-person; however, a shift to a virtual format is possible.
For questions or to be added to our mailing list, please contact Kim Cousineau via email here.
